QIAGEN

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. 

CEO
Thierry L. Bernard
CEOThierry L. Bernard
Employees
5,654
Employees5,654
Headquarters
Venlo, Limburg
HeadquartersVenlo, Limburg
Founded
1996
Founded1996
Employees
5,654
Employees5,654

QGEN Key Statistics

Market cap
8.03B
Market cap8.03B
Price-Earnings ratio
20.01
Price-Earnings ratio20.01
Dividend yield
0.68%
Dividend yield0.68%
Average volume
2.61M
Average volume2.61M
High today
$39.55
High today$39.55
Low today
$38.42
Low today$38.42
Open price
$38.60
Open price$38.60
Volume
3.46M
Volume3.46M
52 Week high
$57.82
52 Week high$57.82
52 Week low
$32.53
52 Week low$32.53

Stock Snapshot

The current QIAGEN(QGEN) stock price is $38.94, with a market capitalization of 8.03B. The stock trades at a price-to-earnings (P/E) ratio of 20.01 and offers a dividend yield of 0.68%.

As of 2026-06-26, QIAGEN(QGEN) stock has fluctuated between $38.42 and $39.55. The current price stands at $38.94, placing the stock +1.4% above today's low and -1.5% off the high.

The QIAGEN(QGEN)'s current trading volume is 3.46M, compared to an average daily volume of 2.61M.

In the last year, QIAGEN(QGEN) shares hit a 52-week high of $57.82 and a 52-week low of $32.53.

In the last year, QIAGEN(QGEN) shares hit a 52-week high of $57.82 and a 52-week low of $32.53.

QGEN News

TipRanks 14h
QIAGEN reports supervisory board member’s vested share award under MAR rules

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

Simply Wall St 1d
Is Qiagen's Digital PCR Expansion Quietly Redefining Its Competitive Moat in Biopharma Tools?

In mid-June 2026, QIAGEN N.V. expanded its QIAcuity digital PCR ecosystem with new gene expression assays, high-multiplex PCR kits, enhanced residual DNA testin...

Is Qiagen's Digital PCR Expansion Quietly Redefining Its Competitive Moat in Biopharma Tools?
TipRanks 1d
Qiagen initiated with a Hold at Kepler Cheuvreux

Kepler Cheuvreux initiated coverage of Qiagen (QGEN) with a Hold rating and $38.60 price target The firm views the company as a “solid franchise,” citing its gr...

Analyst ratings

52%

of 21 ratings
Buy
47.6%
Hold
52.4%
Sell
0%

More QGEN News

Simply Wall St 5d
Qiagen Stock Could Be 15.7% Undervalued After QIAcuity Expansion

Qiagen (NYSE:QGEN) is in focus after announcing new additions to its QIAcuity digital PCR ecosystem, including expanded gene expression tools, higher multiplexi...

Qiagen Stock Could Be 15.7% Undervalued After QIAcuity Expansion

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.